Antibody Bioavailability Drug Delivery Systems Marketing 
Roots Analysis
MARCH 13, 2022
In the last decade alone, the annual number of approvals of biopharmaceuticals (including monoclonal antibodies, recombinant proteins, vaccines and gene therapies), by the US FDA, have steadily risen. Future Evolution of Biopharmaceutical Excipient Manufacturing Market.
XTalks
AUGUST 30, 2022
CNS drugs take more than a year longer to develop and are less than half as likely to receive marketing approval compared to other drugs, according to a 2014 study by the Tufts Center for the Study of Drug Development. Vornov, nusinersen is driving much of what is being currently seen in drug development.
Expert insights. Personalized for you.
52 
Let's personalize your content